Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $142.83 USD
Change Today -0.12 / -0.08%
Volume 842.2K
BDX On Other Exchanges
New York
As of 8:04 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Vincent A. Forlenza

Chairman, Chief Executive Officer, President and Chairman of Executive Committee,Becton, Dickinson and Company
AgeTotal Calculated CompensationThis person is connected to 20 board members in 3 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Vincent A. Forlenza, also known as Vince, has been the Chairman of Becton, Dickinson and Company since July 1, 2012 and has been its President since January 1, 2009 also Chief Executive Officer since October 1, 2011. Mr. Forlenza oversees Becton, Dickinson and Company's three business segments (BD Medical, BD Diagnostics and BD Biosciences), International and the Quality function. He served as the Chief Operating Officer of Becton, Dickinson and Company from July ...

Read Full Background

Corporate Headquarters*

1 Becton Drive
Franklin Lakes, New Jersey 07417

United States

Phone: 201-847-6800
Fax: --

Board Members Memberships*

Chairman of AdvamedDx
Chairman, Chief Executive Officer, President and Chairman of Executive Committee


BS 1975
Lehigh University
MBA 1980
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$985,000

Stock Options*

Restricted Stock Awards$4,653,236
All Other Compensation$35,691
Exercised Options44,041
Exercised Options Value$2,233,762
Exercisable Options331,130
Exercisable Options Value$13,235,302
Unexercisable Options422,789
Unexercisable Options Value$11,084,930
Total Value of Options$26,553,994
Total Number of Options797,960

Total Compensation*

Total Annual Cash Compensation$2,420,691
Total Short Term Compensation$985,000
Other Long Term Compensation$4,688,927
Total Calculated Compensation$10,983,518
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BDX:US $142.83 USD -0.12


Kevin A. Lobo Chairman, Chief Executive Officer and President
Stryker Corporation
Heather Bresch Chief Executive Officer, Executive Director and Member of Science & Technology Committee
Mylan N.V.
Michael F. Mahoney Chief Executive Officer, President and Director
Boston Scientific Corporation
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
Hock E. Tan Chief Executive Officer, President and Executive Director
Avago Technologies Limited
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BECTON DICKINSON AND CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at